Development of a Neonatal Jaundice Treatment Accelerator by Redirection of

Status Withdrawn

Clinical Trial Summary

This is a descriptive prospective study of safety and efficacy of the reflective PT ring device. Neonates with an elevated total serum bilirubin (TSB) meeting PT criteria per their clinician during hospital admission will be eligible for enrollment after informed parental consent.

Clinical Trial Description

Neonatal jaundice (NNJ) continues to be a significant global problem affecting over 80% of neonates while severe neonatal jaundice affects at least 481,000 neonates annually. Jaundice and jaundice related complications like Kernicterus Spectrum Disorder (KDS) are gaining recognition among the world's health policy leaders as an important area for further research and development. The long-term sequelae of KSD include choreoathetoid cerebral palsy, sensorineural hearing loss, and upward gaze palsy. KSD is irreversible resulting in a lifetime of physical, emotional, social and economic challenges. Access to cost-effective methods of improving pediatric jaundice care along with improved circumferential (full body) illumination technologies is an affirmed objective of the AAP (American Academy of Pediatrics). The investigators hypothesize that unused therapy light (irradiance) surrounding the neonate using an existing single-lamp bank phototherapy (PT) device is sufficient in quantity and if redirected onto the patients untreated or poorly illuminated skin surfaces, it will accelerate metabolism and excretion of bilirubin. This PT ring device redirects unused phototherapy light sideways onto the neonate body using an open-faced ring approach. The technology will illuminate previously unexposed and poorly exposed skin regions where treatable bilirubin exists. The device is superior to current PT devices in that it converts existing waste light into treatment efficacy while integrating into existing overhead lamp systems offsetting the purchase of secondary devices that are often unaffordable and create hospital complexity, cost and inefficiency issues. A further benefit of the device will be reduced ambient blue-light spillover in patient care areas, an ongoing concern for medical staff. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04021927
Study type	Interventional
Source	University of Minnesota
Contact
Status	Withdrawn
Phase	N/A
Start date	September 1, 2019
Completion date	January 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00735319` - Transcutaneous Bilirubinometers in the Community	N/A
Completed	`NCT00114543` - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight	Phase 3
Completed	`NCT01887327` - Stannsoporfin With Light Therapy for Newborn Babies With Jaundice	Phase 2
Completed	`NCT04632888` - The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy	N/A
Not yet recruiting	`NCT04527536` - Research of Diagnostic Value for BMJ Infants
Suspended	`NCT03741803` - Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice	N/A
Completed	`NCT05650463` - Evaluation of a Smartphone-based Screening Tool (Picterus Jaundice Pro) for Neonatal Jaundice in Dark Skin Newborns	N/A
Terminated	`NCT05623566` - Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia	N/A
Completed	`NCT02612727` - Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates	N/A
Completed	`NCT01434810` - Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates	N/A
Completed	`NCT03184948` - Understanding Neonatal Jaundice in Rwanda	N/A
Completed	`NCT03942757` - BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
Not yet recruiting	`NCT05806684` - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed	`NCT06372093` - Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in Botswana	N/A
Completed	`NCT03570775` - Effectiveness, Safety and Perceptions With the Use of One LED Sleeping Bag Device in the Treatment of Neonatal Jaundice	N/A
Completed	`NCT03569254` - Effectiveness, Safety and Perceptions With the Use of One LED Blanket Device in the Ambulatory Treatment of Jaundice	N/A
Completed	`NCT05625880` - Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Nepali Population	N/A
Completed	`NCT01169740` - Transcutaneous Measurement of Jaundice in the Newborn	N/A
Completed	`NCT05623553` - Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican Population	N/A
Completed	`NCT03007563` - Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms